Navigation Links
ThermalTherapeutic Systems Announces FDA Clearance of the VERATHERM(TM) Portable Hyperthermic Perfusion System
Date:3/8/2010

PITTSBURGH, March 8 /PRNewswire/ -- ThermalTherapeutic Systems, Inc. today announced that the FDA has cleared the company to market its VERATHERMPortable Hyperthermic Perfusion System effective immediately.

"FDA clearance is a significant achievement for ThermalTherapeutic Systems, one which allows the company to place the VERATHERMPortable Hyperthermic Perfusion System in the hands of surgeons and perfusionists at luminary institutions across the country. For medical professionals -- for those who will benefit from using this technology -- FDA clearance represents a critical step forward in the company's ongoing effort to standardize the use and improve the control of hyperthermic perfusion", said Raymond F. Vennare, CEO of ThermalTherapeutic Systems.

The VERATHERMPortable Hyperthermic Perfusion System is small, lightweight and mobile device which provides the medical community with an economical platform to precisely deliver and circulate heated and unheated sterile fluids to a broad population of patients for a variety of appropriate indications and treatments. This device, the company believes, establishes a new standard for portable hyperthermic perfusion.

J. Michael Fausset, Chief Technology Officer for ThermalTherapeutic Systems -- a perfusionist with thirty years of clinical experience -- believes that the VERATHERMPortable Hyperthermic Perfusion System will not only improve the quality of hyperthermic treatments, in particular, but create opportunities for hospitals and perfusion groups to expand their services in general.

"The fact that this device precisely monitors temperature, pressure and flow allows the physician and technician to have more control over the treatment", said Fausset. "But because of its portability, more patients can be treated at more facilities or in different clinical environments".

Launch of the VERATHERMPortable Hyperthermic Perfusion System begins in April, 2010.

ThermalTherapeutic Systems, Inc. was founded in 2006 by a team of experts in the field of hyperthermic perfusion, medical device manufacturing, molecular diagnostics and technology commercialization. ThermalTherapeutic Systems is a product development company and the VERATHERMPortable Hyperthermic Perfusion System is the company's first product offering. The intended use of this device is to raise the core temperature of the thoracic or peritoneal cavity to the desired temperature by continuous lavage with circulating warmed, physiologically compatible sterile solution, according to a protocol selected by a physician (www.thermaltherapeutics.com).

SOURCE ThermalTherapeutic Systems, Inc.

Back to top

RELATED LINKS
http://www.thermaltherapeutics.com

'/>"/>

SOURCE ThermalTherapeutic Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
2. Corgenix Medical Corp. Announces Launch of Products for Automated Systems
3. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
4. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
5. Internal Fixation Systems to Sponsor and Exhibit at Wallstreet Spring Break Growth and Value Investor Conference in Fort Lauderdale, FL March 3-4, 2010
6. Samplify Systems Next-Generation Prism 3.0 Real-Time Compression IP Named Finalist in EDN Magazines 20th Annual Innovation Awards
7. Varian Medical Systems Showcases Advanced Radiotherapy and Brachytherapy Products at ACRO 2010, February 25-27, Florida, Booth No. 34-35
8. McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010
9. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Pulse Systems Announces New Sales Representation in the Western United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com ... ingestion of their medication by matching users with high quality water pipes within an ... with no commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, ...
Breaking Medicine News(10 mins):